Palumbo Wealth Management LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1846310 GREAT NECK, NY

Position in DSGN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,038,135

+$278,354 QoQ

Shares Held

71,744

+0.5% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.26%

of 13F equity value

Holder Rank

#49

of 137 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Palumbo Wealth Management LLC holds $18,919,930 across 32 Biotechnology names. DSGN ranks #3 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABSI	Absci Corp	183,193	$2,123,206
2	DFTX	Definium Therapeutics, Inc.	29,287	$1,377,660
3	DSGN	Design Therapeutics, Inc. This page	71,744	$1,038,135
4	TSHA	Taysha Gene Therapies, Inc.	149,173	$1,015,868
5	NVAX	Novavax Inc	92,947	$875,560
6	IDYA	IDEAYA Biosciences, Inc.	23,198	$864,589
7	SNDX	Syndax Pharmaceuticals Inc	37,631	$822,613
8	BEAM	Beam Therapeutics Inc.	22,726	$779,956

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,038,135	71,744	+0.5%	Shares	Sole	2026-08-12
2026-03-31	$759,781	71,408	+2.9%	Shares	Defined	2026-05-12
2025-12-31	$650,756	69,377	+33.2%	Shares	Sole	2026-01-21
2025-09-30	$392,169	52,081	-14.0%	Shares	Sole	2025-11-10
2025-06-30	$204,070	60,555	+3.9%	Shares	Sole	2025-07-15
2025-03-31	$224,953	58,278	+6.5%	Shares	Sole	2025-04-22
2024-12-31	$337,474	54,696	+48.7%	Shares	Sole	2025-01-30
2024-09-30	$197,844	36,774	+11.3%	Shares	Sole	2024-10-28
2024-06-30	$110,730	33,054	+94.8%	Shares	Sole	2024-08-02
2024-03-31	$68,397	16,972	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.